Clinical Trial Update: Long-Term Follow-up Study

View source ↗

Summary

Long-term follow-up study of relapsed/refractory non-Hodgkin lymphoma is currently enrolling by invitation, sponsored by Caribou Biosciences.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Multiple Myeloma
• Non-hodgkin Lymphoma

Snippet

Sponsor: Caribou Biosciences, Inc. | Conditions: Lymphoma, Non-Hodgkin, Relapsed Non-Hodgkin Lymphoma | Status: ENROLLING_BY_INVITATION